NigerSince the late 1980s, JSI has been assisting the government of Niger to improve health outcomes in the country starting with the implementation of the Resources for Child Health’s (REACH) initiative to control measles outbreaks through improved immunization systems in the country’s urban areas. JSI has since provided logistical analysis for the supply chain of Zithromax through the International Trachoma Initiative, and has been contracted by the United Nations Population Fund (UNFPA) to manage reproductive health commodities. JSI’s portfolio in Niger covers health issues ranging from family planning to disease prevention.
Read an article on the Health Communication Network website about the SPRING Project's work in Niger: The Father Factor: How Community Video Encourages Male Involvement for Better Nutrition and Hygiene Behaviors in Niger.
PATH and JSI are collaborating with ministries of health and country implementing partners to coordinate DMPA SubQ country introduction and scale-up planning and implementation.
The New Vaccine Introduction (NVI) for GAVI supports the introduction of the HPV vaccine, pentavalent vaccine, pneumococcal conjugate vaccine (PCV), and rotavirus vaccine in three countries.
Trachoma, an infectious eye disease, is the world's leading cause of preventable blindness. JSI is providing technical and logistics support to the International Trachoma Initiative, to treat infected populations with azithromycin.
SPRING is scaling up high-impact nutrition practices and policies by providing technical support on preventing stunting and maternal and child anemia, linking agriculture and nutrition, and changing behavior through communication.
More than a billion people suffer from neglected tropical diseases that cause illness, disability, and loss of productivity. JSI worked to build capacity in supply chain management, including quantification of medicines used for preventive chemotherapy.
JSI provided technical assistance to UNFPA offices and local counterparts to enhance in-country capacity to forecast, finance, procure, and distributed reproductive health commodities and promote RH commodity security policy dialogue.